Inactive Instrument

Calendar ChemoCentryx, Inc.

Equities

CCXI

US16383L1061

Chart calendar ChemoCentryx, Inc.

e9dcb8dbd96856a5b311aeb2.N0pHoQdBXXOTYr1D6z4IucRBsfeuwMRnZrkoP-YjDvA.YS4U0XYOKz-jAMg5oBNlw4cg4Mab-fcyVvFhca0UasFEDwTWfyxsPfQO-A~a8eaf6bba7f089901d512b9fddc534b6

Upcoming events on ChemoCentryx, Inc.

No events available

Past events on ChemoCentryx, Inc.

2022-11-13 10:15 American College of Rheumatology Convergence Conference - Abstract #1077
2022-11-13 10:10 American College of Rheumatology Convergence Conference - Abstract #1076
2022-11-13 09:00 American College of Rheumatology Convergence Conference - Abstract #1078
2022-11-10 15:15 American College of Rheumatology Convergence Conference - Abstract #525
2022-11-10 11:40 Society for Immunotherapy of Cancer Meeting - Abstract Number: 499
2022-11-10 11:40 Society for Immunotherapy of Cancer Meeting - Abstract Number: 769
2022-11-05 10:00 American Society of Nephrology Kidney Conference - Abstract #SA-PO696
2022-11-05 10:00 American Society of Nephrology Kidney Conference - Abstract #SA-PO633
2022-11-04 10:00 American Society of Nephrology Kidney Conference - Abstract #FR-PO651
2022-10-17 Extraordinary Shareholders Meeting - M&A Vote
2022-09-07 Rheumatology Advanced Practice Providers National Conference
2022-09-07 Medscape LIVE! Perspectives in Rheumatic Diseases Conference
2022-08-27 01:30 European Meeting on Complement in Human Disease
2022-08-08 Interim 2022 Earnings Release After hours
2022-06-21 European Society for Pediatric Nephrology Conference
2022-06-05 09:00 American Society of Clinical Oncology Meeting - Abstract No 2593
2022-06-02 04:35 European Alliance of Associations for Rheumatology Conference - Oral Presentation No OP0180
2022-06-01 07:36 European Alliance of Associations for Rheumatology Conference - Poster No POS0835
2022-06-01 07:20 European Alliance of Associations for Rheumatology Conference - Poster No POS0833
2022-05-26 13:00 Annual General Meeting
  1. Stock Market
  2. Equities
  3. CCXI Stock
  4. Calendar ChemoCentryx, Inc.